|
U.S. FDA Bests EMA in Cancer Drug Approval Times, Study Finds
The U.S. Food and Drug Administration (FDA) continues to approve cancer drugs more quickly than the European Medicines Agency (EMA), clearing them in about half the time regardless of the drug’s designation, according to a recent study.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives